ISSN: 2278-0238

薬学および生命科学における研究開発の国際ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

FORMULATION AND EVALUATION OF IMMEDIATE AND SUSTAINED RELEASE BILAYERED TABLET WITH GLIBENCLAMIDE AND METFORMIN HYDROCHLORIDE

Udayakumar T, Suresh A.G, Udhumansha Ubaidulla

The aim of the present research work is to develop bilayer tablet dosage form containing combination of immediate and sustained release layer prepared using Glibenclamide and Metformin Hydrochloride respectively for the treatment of Type-11 diabetes mellitus. Immediate release of glibenclamide granules was prepared with different superdisintegrant. Metformin hydrochloride sustained release granules were prepared by non-aqueous wet granulation technique. Both pre-compression and post compression parameters were analyzed for all the tablets. Bilayer tablets was formulated using croscarmellose sodium for immediate release of Glibenclamide showed 99.94% of release in 30 minutes and using hydrophilic HPMC K100 and hydrophobic Ethyl cellulose in the ratio of 1:1 released 99.90% of Metformin hydrochloride for the period of 13 hours. From this research work it is evident that the formulated bilayer tablet has ability to release the Glibenclamide immediately and Metformin hydrochloride for longer period of time, which can be used for treatment of type11 diabetes mellitus compared to Marketed formulation.